ASX:LCT

Living Cell Technologies (LCT) Stock Price, News & Analysis

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
76,622 shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
LCT stock logo

About Living Cell Technologies Stock (ASX:LCT)

Living Cell Technologies Limited, a biotechnology company, discovers, develops, and commercializes regenerative treatments that use naturally occurring cells to restore functions in Australia and New Zealand. It is developing NTCELL, an alginate-coated capsule, which is in phase IIb clinical trial for the treatment of Parkinson's disease. The company was founded in 1987 and is based in Melbourne, Australia.

LCT Stock News Headlines

Dems have chosen Biden replacement?
On November 16, 2023… Joe Biden accidentally revealed the name of the candidate… Who will replace him in the 2024 presidential election.
Dems have chosen Biden replacement?
On November 16, 2023… Joe Biden accidentally revealed the name of the candidate… Who will replace him in the 2024 presidential election.
Defining a city using cell-phone data
Living Cell Technologies Limited (LVCLF)
See More Headlines
Receive LCT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Living Cell Technologies and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/19/2019
Today
5/03/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
147,000
Year Founded
N/A

Profitability

Net Income
$-2,110,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$3,405.00

Miscellaneous

Outstanding Shares
1,640,000,000
Free Float
N/A
Optionable
Not Optionable
Beta
0.48
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Key Executives

  • Mr. David Richard Hainsworth (Age 50)
    CEO & Exec. Chairman
    Comp: $40k
  • Mr. Daya Uka
    Chief Financial Officer
  • Dr. Belinda Di Bartolo
    Chief Operations Officer
  • Dr. Carolyn M. Sue A.M. (Age 60)
    B.S., Ph.D., Member of Medical Advisory Board & Chief Medical Officer of NTCELL
    Comp: $50k
  • Mr. Madhukar Bhalla FCIS (Age 64)
    Company Sec.
    Comp: $40k
  • Dr. James A. Mckenna
    Chief Scientific Officer

LCT Stock Analysis - Frequently Asked Questions

How were Living Cell Technologies' earnings last quarter?

Living Cell Technologies Limited (ASX:LCT) announced its quarterly earnings data on Tuesday, February, 19th. The company reported $0.00 earnings per share (EPS) for the quarter.

What other stocks do shareholders of Living Cell Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Living Cell Technologies investors own include eWellness Healthcare (EWLL), Energous (WATT), AllianceBernstein Global High Income Fund (AWF).

This page (ASX:LCT) was last updated on 5/3/2024 by MarketBeat.com Staff

From Our Partners